Pulmonary tuberculosis

From IDWiki
Revision as of 21:48, 13 November 2019 by Aidan (talk | contribs) ()

Background

Microbiology

Clinical Presentation

  • Subacute or chronic cough (at least 2 to 3 weeks) eventually becoming productive and occasionally involving hemoptysis
    • Should be suspected in any patient with cough and HIV infection
  • Constitutional symptoms, with fevers, night sweats, and unexplained weight loss
  • Usually from reactivation of latent tuberculosis infection, and usually reactivates in lung apices
  • May transiently improve with partially-active antibiotics such as fluoroquinolones

Investigations

  • Spontaneous sputum, induced sputum, or bronchoalveolar lavage specimens should be sent for
    • Acid-fast staining of a smear
    • Culture
    • PCR

Management

  • Standard HREZ x2mo then HR x4mo
    • Isoniazid 5mg/kg/d, max 300mg daily
    • Rifampin 10mg/kg/d
    • Pyrazinamide 25mg/kg/d, max 2g daily
    • Ethambutol 20mg/kg/d, max 1.2g daily
    • Pyridoxine 25 mg po daily
  • Standard duration for uncomplicated disease is 6 months, but should be extended to 9 months if high-risk (including smear positive at 2 months or cavitations)
  • Airborne precautions until:
    • Treated for at least 2 weeks
    • 3x negative sputum smears, which can be collected hourly, but ideally at 8- to 24-hour intervals, including one early morning collection
    • Improvement in symptoms

References

  1. ^  Chandrasekaran Padmapriydarsini, Megha Mamulwar, Anant Mohan, Prema Shanmugam, N S Gomathy, Aarti Mane, Urvashi B Singh, Nathella Pavankumar, Abhijeet Kadam, Hemanth Kumar, Chandra Suresh, Devaraju Reddy, Poornaganga Devi, P M Ramesh, Lakshmanan Sekar, Shaheed Jawahar, R K Shandil, Manjula Singh, Jaykumar Menon, Randeep Guleria. Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis. Clinical Infectious Diseases. 2021;75(3):425-434. doi:10.1093/cid/ciab964.